MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock-Two...
$3,484K
Proceeds from issuance of
common stock-Two...
$2,949K
Proceeds from march 2025
convertible notes
$1,366K
Proceeds from issuance of
common stock from...
$112K
Proceeds from issuance of
common stock-Equity...
$25K
Net cash provided by
financing activities
$7,416K
Canceled cashflow
$520K
Net decrease in cash
and cash...
-$14K
Canceled cashflow
$7,416K
Change in fair value of
warrant liabilities
$5,607K
Loss upon issuance of
march 2025...
$1,198K
Stock-based compensation
expense
$531K
Financing expense for
entering into 2025...
$412K
Prepaid expenses and
other assets
-$242K
Non-cash lease expense
$169K
Depreciation and
amortization
$112K
Inventories
-$68K
Loss on impairment
and disposal of...
-$1K
Principal repayment of
decd loan
$233K
Payment of stock
issuance costs-Two...
$147K
Payment of stock
issuance costs-Two...
$140K
Net cash used in
operating activities
-$7,029K
Canceled cashflow
$8,340K
Net cash used in
investing activities
-$401K
Net loss
-$12,780K
Accrued liabilities
-$1,148K
Accounts payable
-$936K
Accounts receivable
$217K
Change in fair value of
march 2025...
-$170K
Other liabilities
-$118K
Purchase of intangible
assets
$385K
Purchase of property and
equipment
$16K
Back
Back
Cash Flow
source: myfinsight.com
Aspira Women's Health Inc. (AWHL)
Aspira Women's Health Inc. (AWHL)